It’s known that 18F-FCH is better than 18F- Floride in early detection of bone marrow metastases. This evidences, also published in Eur J Nucl Med Mol Imaging (2008) 35:1766-1774 will change clinical management of patients.
We have required to the relevant regulatory Competent Authority the authorisation for a phase three clinical trial to accurately detect early bone metastases in case of prostate cancer, that might not be detected using conventional available methods.
Would you like to be an investigator of this clinical trial? What about this in your experience? Contact us for any questions, ideas or doubt in regard to this argument.
Acom Group
